Moderna
MRNA
#290
Rank
โ‚ฌ71.92 B
Marketcap
177,76ย โ‚ฌ
Share price
-2.17%
Change (1 day)
763.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚ฌ2.63 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚ฌ2.21 Billion. In 2025 the company made an earning of -โ‚ฌ2.52 Billion, an increase over its 2024 earnings that were of -โ‚ฌ3.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ2.63 Billion4.51%
2025 -โ‚ฌ2.52 Billion-23.03%
2024 -โ‚ฌ3.27 Billion-8.22%
2023 -โ‚ฌ3.56 Billion-140.65%
2022 โ‚ฌ8.75 B-27.81%
2021 โ‚ฌ12.12 B-1911.15%
2020 -โ‚ฌ0.67 Billion44.7%
2019 -โ‚ฌ0.47 Billion28.63%
2018 -โ‚ฌ0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ11.52 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ6.12 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚ฌ43.24 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ38.08 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ1.11 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚ฌ0.15 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA